WARNING

Ultomiris (ravulizumab) is a medication primarily used to treat paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disorder. Like any medication, Ultomiris comes with potential risks and side effects. It’s important to note that the information provided here is a general overview, and individuals should consult with their healthcare professionals for personalized advice.

Some potential risks and side effects of Ultomiris may include:

• Infections: Ultomiris may increase the risk of serious infections, including meningococcal infections. Patients are typically advised to receive meningococcal vaccines before starting Ultomiris treatment.
• Allergic Reactions: Some individuals may experience allergic reactions to Ultomiris. Signs of an allergic reaction may include rash, itching, swelling, severe dizziness, or difficulty breathing.
• Risk of Meningococcal Infections: Ultomiris can increase the risk of meningococcal infections, which can be severe and potentially life-threatening. Patients are usually advised to remain vigilant for symptoms of meningococcal infection and seek prompt medical attention if they occur.
• Infusion-related Reactions: Some people may experience infusion-related reactions during or after receiving Ultomiris. These reactions may include headache, fever, chills, or changes in blood pressure.
• High Blood Pressure: Ultomiris may cause an increase in blood pressure. Monitoring blood pressure regularly is recommended during treatment.
• Liver Problems: In rare cases, Ultomiris may be associated with liver problems. Regular monitoring of liver function may be necessary.
• Other Side Effects: Common side effects of Ultomiris may include respiratory tract infections, headache, and upper respiratory tract infections.

It’s crucial for individuals considering or undergoing Ultomiris treatment to discuss their medical history and any existing health conditions with their healthcare provider. Additionally, patients should report any unusual or severe symptoms to their healthcare team promptly. This information provides a general overview, and specific risks may vary from person to person. Always follow the guidance of your healthcare professional and the prescribing information for Ultomiris.

Why is this medication prescribed?

Ultomiris (ravulizumab) is a medication primarily used to treat paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disorder. Like any medication, Ultomiris comes with potential risks and side effects. It’s important to note that the information provided here is a general overview, and individuals should consult with their healthcare professionals for personalized advice.

How should this medicine be used?

Some potential risks and side effects of Ultomiris may include:

• Infections: Ultomiris may increase the risk of serious infections, including meningococcal infections. Patients are typically advised to receive meningococcal vaccines before starting Ultomiris treatment.
• Allergic Reactions: Some individuals may experience allergic reactions to Ultomiris. Signs of an allergic reaction may include rash, itching, swelling, severe dizziness, or difficulty breathing.
• Risk of Meningococcal Infections: Ultomiris can increase the risk of meningococcal infections, which can be severe and potentially life-threatening. Patients are usually advised to remain vigilant for symptoms of meningococcal infection and seek prompt medical attention if they occur.
• Infusion-related Reactions: Some people may experience infusion-related reactions during or after receiving Ultomiris. These reactions may include headache, fever, chills, or changes in blood pressure.
• High Blood Pressure: Ultomiris may cause an increase in blood pressure. Monitoring blood pressure regularly is recommended during treatment.
• Liver Problems: In rare cases, Ultomiris may be associated with liver problems. Regular monitoring of liver function may be necessary.
• Other Side Effects: Common side effects of Ultomiris may include respiratory tract infections, headache, and upper respiratory tract infections.

It’s crucial for individuals considering or undergoing Ultomiris treatment to discuss their medical history and any existing health conditions with their healthcare provider. Additionally, patients should report any unusual or severe symptoms to their healthcare team promptly. This information provides a general overview, and specific risks may vary from person to person. Always follow the guidance of your healthcare professional and the prescribing information for Ultomiris.

Other uses for this medicine

As of last update, Ultomiris is primarily indicated for PNH. It’s important to consult with a healthcare professional for the latest information on approved uses.

What special precautions should I follow?

As for special precautions when using Ultomiris, it’s crucial to discuss these with your healthcare provider, who can provide guidance based on your individual health status. However, some general precautions associated with Ultomiris use include:

• Meningococcal Vaccination: Prior to starting Ultomiris, individuals are usually required to receive meningococcal vaccines to reduce the risk of meningococcal infections associated with this medication.
• Monitoring for Infections: Ultomiris may increase the risk of serious infections, so it’s important to monitor for signs of infection and seek prompt medical attention if symptoms arise.
• Infusion-Related Reactions: Some individuals may experience infusion-related reactions during or after receiving Ultomiris. Monitoring for such reactions and seeking immediate medical attention if they occur is advised.
• Monitoring Blood Pressure: Ultomiris may lead to an increase in blood pressure, and regular monitoring of blood pressure is typically recommended during treatment.
• Liver Function Monitoring: Periodic monitoring of liver function may be necessary, as rare cases of liver problems have been associated with Ultomiris.

Always follow your healthcare provider’s instructions and inform them of any pre-existing medical conditions, medications, or concerns you may have. Do not make changes to your treatment plan without consulting your healthcare team. They are in the best position to provide personalized advice based on your individual health profile and the latest medical information.

What special dietary instructions should I follow?

Regarding special dietary instructions, there are no specific dietary restrictions or instructions associated with Ultomiris that are commonly mentioned. However, individual health conditions and dietary needs can vary, so it’s advisable to discuss any specific concerns or questions about diet with your healthcare provider.

What should I do if I forget a dose?

If you forget a dose of Ultomiris, it’s crucial to contact your healthcare provider or the treatment center as soon as possible. They can provide guidance on how to proceed, whether that involves rescheduling the missed dose or adjusting the treatment plan. It’s not advisable to make decisions about missed doses without consulting a healthcare professional, as maintaining a consistent treatment schedule is important for the effectiveness of the medication.

What side effects can this medication cause?

Ultomiris (ravulizumab) may cause side effects, and it’s important to be aware of potential adverse reactions. Keep in mind that not everyone will experience these side effects, and their severity can vary. It’s crucial to promptly report any unusual or severe symptoms to your healthcare provider. Some common and serious side effects associated with Ultomiris include:

• Infections: Ultomiris may increase the risk of serious infections, including meningococcal infections. Patients are usually required to receive meningococcal vaccines before starting treatment.
• Infusion-Related Reactions: Some individuals may experience infusion-related reactions during or after receiving Ultomiris. Symptoms may include headache, fever, chills, or changes in blood pressure.
• Risk of Meningococcal Infections: Due to the increased risk of meningococcal infections, patients are advised to remain vigilant for symptoms of meningococcal infection and seek prompt medical attention if they occur.
• High Blood Pressure: Ultomiris may cause an increase in blood pressure. Regular monitoring of blood pressure is typically recommended during treatment.
• Liver Problems: In rare cases, Ultomiris may be associated with liver problems. Regular monitoring of liver function may be necessary.
• Allergic Reactions: Some individuals may experience allergic reactions to Ultomiris. Signs of an allergic reaction may include rash, itching, swelling, severe dizziness, or difficulty breathing.
• Respiratory Tract Infections: Common side effects may include respiratory tract infections, headache, and upper respiratory tract infections.

It’s important to note that this is not an exhaustive list of side effects, and other side effects may occur. Additionally, the information provided here is based on last update, and there may have been updates or changes since then. Always consult with your healthcare provider and carefully review the prescribing information for Ultomiris to understand the specific risks and side effects associated with your treatment.

What should I know about storage and disposal of this medication?

Storage:

• Refrigeration: Ultomiris is typically stored in the refrigerator. Follow the specific storage temperature recommended by the manufacturer. Do not freeze the medication.
• Protect from Light: Keep Ultomiris in its original packaging or another container that protects it from light.
• Do Not Shake: Avoid shaking the medication, as this can affect its stability.

Disposal:

• Consult with Healthcare Provider: Ask your healthcare provider or pharmacist for guidance on the proper disposal of Ultomiris. They may provide specific instructions based on your location and local regulations.
• Dispose of Sharps Properly: If Ultomiris is administered using syringes or other sharp objects, dispose of them in an appropriate sharps container.

In case of emergency/overdose

In the case of an emergency or overdose, seek immediate medical attention. Contact your local poison control center or emergency room. It’s essential to have the packaging or information about the medication available for healthcare providers.

What other information should I know?

• Regular Monitoring: Your healthcare provider may conduct regular monitoring of your health, including blood tests, to assess the effectiveness and safety of Ultomiris.
• Follow-Up Appointments: Attend all scheduled follow-up appointments with your healthcare provider. These visits are important for monitoring your response to treatment and addressing any concerns.
• Meningococcal Vaccination: Ensure that you have received the necessary meningococcal vaccinations as advised by your healthcare provider before starting Ultomiris.

Always follow the specific instructions provided by your healthcare provider and the medication’s prescribing information. If you have questions or concerns about Ultomiris, do not hesitate to contact your healthcare team. This information is a general guideline and may not cover all specific aspects of your treatment.